Welcome to our dedicated page for Lifeway Food news (Ticker: LWAY), a resource for investors and traders seeking the latest updates and insights on Lifeway Food stock.
Lifeway Foods Inc. reports developments tied to its kefir-centered fermented dairy business. The company manufactures and markets drinkable kefir, Organic Lifeway Kefir, farmer cheese, other cheeses, ProBugs products for children, frozen kefir and private-label dairy items through retail, broker and distributor channels.
Recurring news themes include financial results and sales outlooks, growth in kefir and farmer cheese demand, product collaborations with foodservice and wellness partners, and brand campaigns that position kefir as a protein-forward probiotic beverage. Company updates also cover distribution, product innovation and consumer-marketing activity across its fermented probiotic portfolio.
Lifeway Foods (Nasdaq: LWAY) reported record results for Q2 2024, with net sales of $49.2 million, up 25.3% year-over-year. This marks the company's 19th consecutive quarter of year-over-year growth. The increase was primarily driven by higher volumes of branded drinkable kefir. Gross profit margin was 27.0%, while SG&A expenses were 15.8% of net sales. Net income reached $3.8 million, or $0.26 per basic share and $0.25 per diluted share, compared to $3.2 million in Q2 2023. CEO Julie Smolyansky highlighted the strong demand for bioavailable foods like Lifeway Kefir and Farmer Cheese, and the effectiveness of their sales and marketing investments in driving trial and capturing new customers.
Lifeway Foods, Inc. (Nasdaq: LWAY), a leading U.S. supplier of kefir and fermented probiotic products, has announced that it will release its second quarter 2024 financial results on August 13, 2024, before market hours. The company, which focuses on products supporting the microbiome, will make available a pre-recorded conference call and webcast featuring Julie Smolyanksy, Lifeway's President and CEO. This presentation will discuss the results and provide additional details.
Investors and interested parties can access the conference call and webcast through the 'Investor Relations' section of Lifeway's website at https://lifewaykefir.com/webinars-reports/. The materials will be available simultaneously with the release of the Q2 results on August 13, 2024, before the market opens.
Ludmila and Edward Smolyansky, owning about 29% of Lifeway Foods (NASDAQ: LWAY), are demanding the resignation of CEO Julie Smolyansky and certain directors. They cite underperformance and mismanagement as reasons for this action. The Smolyanskys previously called for CEO replacement in February 2022, which led to a 50% stock price increase. They're now seeking resignations of lead director Jason Scher, directors Pol Sikar, Jody Levy, Dorri McWhorter, and Perfecto Sanchez.
The Smolyanskys also call for the immediate termination of Julie Smolyansky's spouse, Jason Burdeen, and the adoption of an anti-nepotism policy. They highlight Lifeway's stock underperformance, with shares losing about 54% of value since May 10, 2024. They criticize the CEO's credibility in discussing historical results and the company's marketing strategy.
Ludmila and Edward Smolyansky, who own about 29% of Lifeway Foods Inc. (NASDAQ: LWAY), are demanding the resignation of the company's board of directors and CEO Julie Smolyansky. They cite breaches of fiduciary duty, mismanagement, and underperformance. The Smolyanskys are calling for:
1. A new independent board with up to 8 members
2. Immediate termination of Julie Smolyansky's spouse, Jason Burdeen
3. Adoption of an anti-nepotism policy
4. Operational and strategic review of the business
The letter highlights concerns about the company's performance, governance issues, and alleged misuse of company resources. Since May 2024, LWAY's stock has lost over 130% of its value, underperforming recent analyst estimates.
Lifeway Foods, a leading U.S. supplier of kefir and probiotic products, has been added to the Russell 2000 and Russell 3000 Indexes following the 2024 Russell Index reconstitution. This addition is effective from the start of U.S. equity markets on July 1, 2024. The company's inclusion in these indexes is expected to boost its visibility among institutional investors. CEO Julie Smolyansky highlighted Lifeway's consistent financial performance, noting 18 consecutive quarters of revenue growth and 4 consecutive quarters of record net sales. The Russell indexes are key benchmarks for investment managers and institutional investors.
Pure Culture Organics (PCO) announced a significant litigation update, revealing that Lifeway Foods (NASDAQ: LWAY) has dismissed its claims against PCO. PCO's Co-founder and President, Edward Smolyansky, expressed satisfaction with the outcome, allowing the company to focus on new product developments.
PCO is introducing Pure Culture Organics+ Kids Pouches with Collagen, aimed at children and featuring collagen peptides. Additionally, PCO plans to launch a new lineup of kefirs with flavors like Wild Blueberry and Vanilla Peach, supported by an engaging promotional video.
On May 31, 2024, PCO's philanthropic arm, The Ludmila and Edward Smolyansky Foundation, committed $1 million to the Ann & Robert H. Lurie Children's Hospital of Chicago.
Lifeway Foods (Nasdaq: LWAY) reported record financial results for Q1 2024, ending March 31. Net sales reached $44.6 million, up 17.8% year-over-year, driven by volume growth in Lifeway Kefir. This marks the 18th consecutive quarter of year-over-year growth and the 4th consecutive quarter of record net sales. Gross profit margin expanded by 410 basis points to 25.8%, attributed to higher volumes and lower transportation costs. Net income increased to $2.4 million or $0.17 per basic share, compared to $0.8 million or $0.06 per share in Q1 2023. Selling, general, and administrative expenses remained steady at 17.6% of net sales for both periods.
CEO Julie Smolyansky highlighted strong operational execution and strategic investments in sales and marketing as key drivers behind the company's performance. Lifeway is exploring additional brand marketing and distribution opportunities to sustain growth throughout 2024.
Lifeway Foods, Inc. (Nasdaq: LWAY) praises a recent study on the effects of probiotics in dairy kefir on the microbiome in children with ADHD. The study suggests that probiotics in kefir can positively impact the gut microbiome, potentially reducing ADHD symptoms and improving sleep. Lifeway Foods is encouraged by the findings and remains committed to providing probiotic products for better health.
Lifeway Foods, Inc. (Nasdaq: LWAY) will release its financial results for the first quarter of 2024 on May 14, 2024. The company specializes in kefir and probiotic products. The announcement includes a pre-recorded conference call and webcast with Julie Smolyansky, Lifeway's CEO, discussing the results.
Summary not available.